Publications
- The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database2018 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Peripheral T-cell lyphoma, unspecified - the analysis of the data from the Czech Lymphoma Study Group (CLSG) registry2007 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The occurrence of CNS relapses in high-risk aggressive lymphoma patients treated with intensified induction and high-dose consolidation protocols of the Czech Lymphoma Study GroupPublication without faculty affiliation
- Rituximab significanly improves the outcome of Young poor risk patients with Diffuse Large B-Cell Lymphoma - on behalf of Czech Lymphoma Study GroupPublication without faculty affiliation
- Rituximab signifikntně zlepšuje osud mladých nemocných s difúzním velkobuněčným lymfomem (DLBCL) a špatným prognostickým rizikem dle IPIPublication without faculty affiliation
- Periferní T-non Hodgkinské lymfomy: analýza dat z registru Kooperativní lymfomové skupiny (KLS) ČRPublication without faculty affiliation
- Favorable outcome of high-risk mediastnal diffuse large B-cell lymphoma(DLBCL) after dose-intensive chemoterapy, rituximab and autologous transplant(ASCT)Publication without faculty affiliation
Loading network view...